Diminished liver microperfusion in Fontan patients: A biexponential DWI study

Hildebrand Dijkstra1, Djoeke Wolff2, Joost P van Melle3

  • 1Center for Medical Imaging-North East Netherlands, Department of Radiology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.

Plos One
|March 4, 2017
PubMed

Insights

Decreased liver apparent diffusion coefficients (ADC) in Fontan circulation patients are due to reduced microperfusion, not molecular diffusion changes. Over time, molecular diffusion also decreases, indicating early intracellular changes before fibrosis.

Area of Science:

  • Radiology
  • Hepatology
  • Cardiology

Background:

  • Hepatic apparent diffusion coefficients (ADC) decrease in Fontan circulation patients, but the cause (diffusion vs. microperfusion) is unclear.
  • Understanding this distinction is crucial for managing potential liver disease in these patients.

Purpose of the Study:

  • To differentiate between true molecular diffusion and microperfusion in Fontan circulation livers using intravoxel incoherent motion (IVIM) modeling.
  • To compare these parameters with a control group and correlate them with liver function and disease progression.

Main Methods:

  • 1.5T MRI with diffusion-weighted imaging (DWI) was used to examine 59 Fontan patients and 19 controls.
  • IVIM parameters (Dslow, Dfast, ffast) and ADC were calculated for liver segments.
  • Correlations were made with clinical data, follow-up duration, and liver function tests.

Main Results:

  • Fontan livers showed significantly reduced microperfusion (Dfast, ffast) compared to controls.
  • Molecular diffusion (Dslow) was similar, but ADC was lower in Fontan patients.
  • ADC and Dslow decreased with longer follow-up duration post-Fontan, while microperfusion remained stable.

Conclusions:

  • Decreasing ADC in Fontan livers primarily reflects reduced hepatic microperfusion, not altered molecular diffusion.
  • Long-term, both molecular diffusion and ADC decline post-Fontan, suggesting early intracellular changes preceding fibrosis and cirrhosis.